Anjaneyulu Vinukonda

Anjaneyulu Vinukonda

Auto-generated profile, based on publicly available information

Anjaneyulu Vinukonda

Strides Pharma Inc., USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 November 2024 in Journal of Biomaterials Science, Polymer Edition
Verified
Journal Article
Closed access
RTRUCHI TIWARI
RUCHI TIWARI
APAnasuya Patil
Anasuya Patil
RVRitu Verma
Ritu Verma
VDVarsha Deva
Varsha Deva
SRShashi Ravi Suman Rudrangi
Shashi Ravi Suman Rudrangi
AVAnjaneyulu Vinukonda
Anjaneyulu Vinukonda

21 February 2025
Verified
Book Chapter
Closed access
ABAditi Bhardwaj
Aditi Bhardwaj
Dr. Vijayakumar SubramaniyanDr. Vijayakumar Subramaniyan
Dr. Vijayakumar Subramaniyan
AVAnjaneyulu Vinukonda
Anjaneyulu Vinukonda
KRK. Ramakrishna
K. Ramakrishna
SSShivam Srivastava
Shivam Srivastava
PSPankaj Sharma
Pankaj Sharma
Research and development (R&D) across a range of sectors is being profoundly transformed by the emergence of robots and automation. This chapter examines the significant effects of these technologies on research and development procedures, emphasizing the ways in which automation and robots improve productivity, accuracy, and creativity. Increased repeatability of outcomes, real-time data processing, and high-throughput experiments are made possible by the integration of robotic systems in lab and industrial settings. Cutting-edge robotics, including autonomous systems and collaborative robots (cobots), is propelling progress in industries like biotechnology, medicine, materials research, and manufacturing. Integrating robots and automation will be essential for sustaining a competitive edge and promoting environmentally friendly innovation as we traverse the future terrain of scientific inquiry. In order to revolutionize research and development, this chapter attempts to give a thorough overview of the status of robotics and automation today and in the future.

30 May 2023 in World Journal of Advanced Research and Reviews
Verified
Journal Article
Open access
PDF file
AVAnjaneyulu Vinukonda
Anjaneyulu Vinukonda
SASiva Anka Rao. A
Siva Anka Rao. A
Vaccine research is supported by related fields like microbiology, biochemistry, and immunology. These lead to development of new vaccines for immunization of many diseases. In the pipeline there are more than 500 vaccines which are being extended to some form of peanut allergy, coronary artery diseases, cervical cancer, blindness, gastric ulcers, diabetes etc. New Vaccines against HIV, TB and Malaria are developing by researchers are still under development process because knowledge in some other areas are also important. Many traditional vaccines require multiple injections to provide effective patient protection these lead to costly and inconvenient regimen which gives a idea about single shot vaccines. The single shot vaccines can provide protection with only one injection for curing diseases1. During the development and manufacturing process of single shot vaccines the complex factors must be controlled for a significant influence on efficacy of immune response. Single shot vaccination concept is widely applicable to different types of antigens and vaccines. In future the research is required to know the adjuvants influence and release characteristics in different vaccination regimens.

10 November 2026 in Journal of Drug Delivery Science and Technology
Verified
Journal Article
Closed access
RKRavi Kiran Kaja
Ravi Kiran Kaja
AVAnjaneyulu Vinukonda
Anjaneyulu Vinukonda

15 May 2023 in Journal of Drug Delivery and Therapeutics
Verified
Journal Article
Open access
PDF file
VPVijay Srinivas P
Vijay Srinivas P
GKGana Manjusha K
Gana Manjusha K
AVAnjaneyulu Vinukonda
Anjaneyulu Vinukonda
To evaluate and quantify Irinotecan (R-enantiomer) / Irinotecan related compound D in Irinotecan hydrochloride trihydrate API, a high stereo-specific liquid chromatography technique was developed and validated. The partition was accomplished on ChiralpakIC-3 (150 x 4.6 mm 3µm) through a mobile fragment comprising 0.1 % v/v Formic acid in water and acetonitrile with 1mL/min, 250C, 20µL, 50C and 370 nmas flow rate, column temparture, injection volume, sample cooler temperature and detection wavelength. At 8.903 and 9.75 min, the retention time of Irinotecan (R-enantiomer) and Irinotecan (S-enantiomer) was determined. The resolution between Irinotecan (R-enantiomer) and Irinotecan (S-enantiomer) was found to be 2.4. The impurity acceptance limit is 0.2 %. The established method's precision, accuracy, sensitivity, linearity, specificity, and ruggedness were all verified in accordance with ICH recommendations. The qualifying sample LOQ was found to be 0.4 g/ml, while the minimal amount of sample needed for LOD detection was found to be 0.12 g/ml. The proposed reversed-phase method has been sophisticated and authenticated in accordance with ICH criteria and is capable of quantifying irinotecan enantiomer in irinotecan hydrochloride trihydrate API at trace level concentration. The specificity, linearity, and accuracy of the approach were used to guarantee its efficacy; as a result, it is appropriate for the task at hand, may be used successfully for routine laboratory analysis, and can be utilised for quality control. Keywords: Irinotecan, liquid chromatography technique, enantiomer impurity

15 May 2021 in Journal of Drug Delivery and Therapeutics
Verified
Journal Article
Open access
PDF file
GNGovind Raju. N
Govind Raju. N
SOShishir Ojha
Shishir Ojha
SRSumit Kumar Roy
Sumit Kumar Roy
AKAmit Kori
Amit Kori
AVAnjaneyulu Vinukonda
Anjaneyulu Vinukonda
Sterile generic dosage development requires that specific critical quality attributes be considered and evaluated, regardless of the route of delivery or the type of registration application. The review briefed with an overview of Pharmaceutical Development study requirements. Each of the various stages of studies like Compatibility with the packaging materials, manufacturing vessels, processing aids, MOCs, Filters, Tubing’s and Gaskets also with special studies to be conducted as part of Regulatory Submission, process considerations. Thus, the chapter offers the formulator an overview of the foundational principles associated with formulation development /Pre-formulation studies of sterile products. Keywords: Pharmaceutical Development, Compatibility, Studies, Hold time.